Aquablation therapy is a relatively new, noninvasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). Medicare covers one treatment, but conditions apply.

Today's video is a must-watch for men approaching their golden years, as we delve into a topic pertinent to many: benign ...

The following is a summary of “A cross-tissue transcriptome-wide association study identifies new susceptibility genes for benign prostatic hyperplasia,” published in the January 2025 issue of Urology ...

At some point in their lives, nearly all men will experience some degree of prostate enlargement. Understanding the risk ...

Benign prostatic hyperplasia is a non-cancerous enlargement of the prostate. It can block or narrow the tube that urine passes through to leave the body (urethra), which can cause lower urinary tract ...

Transperineal laser ablation (TPLA) can be used to treat lower urinary tract symptoms of benign prostatic hyperplasia in the NHS while more evidence is generated, in people who cannot have ...

Lucknow: The urology department at Ram Manohar Lohia Institute of Medical Sciences (RMLIMS) has for the first time successfully treated two patients w.

A recent study published in the journal Urology found that Aquablation effectively improved urinary function and preserved or even enhanced sexual function in men with localized p ...

AI-powered planning and robotic precision revolutionize treatment, preserving continence and sexual functionNew York, NY, Jan ...

KBC Group NV lifted its position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 46.0% during the 4th quarter, Holdings Channel.com reports. The fund owned 2,236 shares of the ...